Taipei Exchange - Delayed Quote TWD

Lukas Biomedical Inc. (6814.TWO)

25.10
0.00
(0.00%)
At close: 12:19:50 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
189,828
189,828
231,833
184,787
157,618
Cost of Revenue
76,712
76,712
97,943
86,881
61,555
Gross Profit
113,116
113,116
133,890
97,906
96,063
Operating Expense
205,053
205,053
177,454
146,475
140,313
Operating Income
-91,937
-91,937
-43,564
-48,569
-44,250
Net Non Operating Interest Income Expense
-2,579
-2,579
-2,982
-2,847
-4,372
Pretax Income
-94,473
-94,473
-47,275
-49,919
-47,832
Tax Provision
-95
-95
78
151
1,662
Net Income Common Stockholders
-94,378
-94,378
-47,353
-50,070
-49,494
Diluted NI Available to Com Stockholders
-94,378
-94,378
-47,353
-50,070
-49,494
Basic EPS
-2.38
--
-1.28
-1.35
-1.50
Diluted EPS
-2.38
--
-1.28
-1.35
-1.50
Basic Average Shares
39,654.62
--
36,994.53
37,005.38
33,079.94
Diluted Average Shares
37,105.51
39,654.62
36,994.53
37,005.38
33,079.94
Total Expenses
281,765
281,765
275,397
233,356
201,868
Net Income from Continuing & Discontinued Operation
-94,378
-94,378
-47,353
-50,070
-49,494
Normalized Income
-94,178.20
-94,178.20
-47,356.20
-50,152.40
-50,443.60
Interest Income
461
461
90
73
43
Interest Expense
3,040
3,040
3,072
2,920
4,415
Net Interest Income
-2,579
-2,579
-2,982
-2,847
-4,372
EBIT
-91,433
-91,433
-44,203
-46,999
-43,417
EBITDA
-62,878
-62,878
-12,571
-10,932
-361
Reconciled Cost of Revenue
76,712
76,712
97,943
86,881
61,555
Reconciled Depreciation
28,555
28,555
31,632
36,067
43,056
Net Income from Continuing Operation Net Minority Interest
-94,378
-94,378
-47,353
-50,070
-49,494
Total Unusual Items Excluding Goodwill
-200
-200
4
103
1,187
Total Unusual Items
-200
-200
4
103
1,187
Normalized EBITDA
-62,678
-62,678
-12,575
-11,035
-1,548
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-0.20
-0.20
0.80
20.60
237.40
12/31/2021 - 12/31/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

4197.TWO Visgeneer Inc.
10.00
-4.31%
 
7725.TWO LabTurbo Biotech Corporation
22.00
0.00%
 
4170.TWO VBI
13.00
0.00%
 
6999.TWO Han Biomedical
41.20
0.00%
 
6848.TWO RBC Bioscience Corporation
18.20
0.00%
 
6610.TWO TWi Biotechnology, Inc.
11.05
+0.45%
 
6709.TWO Advagene Biopharma Co., Ltd.
17.30
0.00%
 
6652.TWO Eusol Biotech Co.,Ltd.
6.11
-1.77%
 
6810.TWO Bio Preventive Medicine Corp.
23.00
+0.44%
 
6827.TWO MegaPro Biomedical Co., Ltd
9.84
+0.41%